mannitol has been researched along with carboplatin in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (83.33) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Popelár, J; Syka, J; Taudy, M; Ulehlová, L | 1 |
| Frenkel, EP; Henner, WD; Mickey, BE; Neuwelt, EA; Wiliams, PC | 1 |
| Cornelison, TL; Reed, E | 1 |
| Gemma, A; Hayashihara, K; Kudoh, S; Niitani, H; Shibuya, M; Taniguchi, Y; Uematsu, K; Yamano, Y; Yoshimori, K; Yoshimura, A | 1 |
| Garcia, R; Mass, M; McCormick, CI; Neuwelt, EA; Pearse, HD; Remsen, LG; Roman-Goldstein, S; Sexton, G | 1 |
| Dragounová, E; Dvorák, J; Hyspler, R; Kalábová, H; Melichar, B; Tichá, A | 1 |
1 review(s) available for mannitol and carboplatin
| Article | Year |
|---|---|
Nephrotoxicity and hydration management for cisplatin, carboplatin, and ormaplatin.
Topics: Animals; Antineoplastic Agents; Carboplatin; Cisplatin; Fluid Therapy; Furosemide; Humans; Kidney; Mannitol; Organoplatinum Compounds; Saline Solution, Hypertonic | 1993 |
1 trial(s) available for mannitol and carboplatin
| Article | Year |
|---|---|
[An early phase II trial combining cisplatin and carboplatin in advanced non-small cell lung cancer].
Topics: Adult; Aged; Anorexia; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Cisplatin; Drug Administration Schedule; Female; Furosemide; Humans; Infusions, Intravenous; Lung Neoplasms; Male; Mannitol; Methylprednisolone; Metoclopramide; Middle Aged; Nausea | 1993 |
4 other study(ies) available for mannitol and carboplatin
| Article | Year |
|---|---|
Carboplatin and cisplatin ototoxicity in guinea pigs.
Topics: Acoustic Stimulation; Animals; Auditory Threshold; Carboplatin; Cisplatin; Cochlea; Drug Combinations; Ear, Inner; Electrodes, Implanted; Female; Guinea Pigs; Hair Cells, Auditory; Hearing; Injections, Intraperitoneal; Mannitol | 1992 |
Therapeutic dilemma of disseminated CNS germinoma and the potential of increased platinum-based chemotherapy delivery with osmotic blood-brain barrier disruption.
Topics: Adolescent; Adult; Blood-Brain Barrier; Brain; Brain Neoplasms; Carboplatin; Cisplatin; Etoposide; Female; Germinoma; Hearing Loss, High-Frequency; Humans; Magnetic Resonance Imaging; Male; Mannitol; Platinum; Treatment Outcome | 1994 |
Long-term toxicity and neuropathology associated with the sequencing of cranial irradiation and enhanced chemotherapy delivery.
Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Blood-Brain Barrier; Brain; Carboplatin; Chemotherapy, Adjuvant; Combined Modality Therapy; Cranial Irradiation; Dose-Response Relationship, Radiation; Drug Administration Schedule; Etoposide; Mannitol; Methotrexate; Radiation Injuries, Experimental; Radiotherapy, Adjuvant; Rats; Treatment Outcome | 1997 |
Gastrointestinal permeability in ovarian cancer and breast cancer patients treated with paclitaxel and platinum.
Topics: Adenocarcinoma; Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carboplatin; Cell Membrane Permeability; Cisplatin; Female; Gastrointestinal Tract; Humans; Intestinal Absorption; Lactulose; Mannitol; Middle Aged; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Paclitaxel; Sucrose; Trastuzumab; Xylose | 2007 |